Delivery Order SPE2DB20D3103-SPE2DB23FP6Y9
Award Date
9/12/23
Potential Completion Date
9/13/23
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $14,971.67 delivery order contract is for the supply of Vyvanse capsules (30mg) and has a period of performance through December 1, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,456.05 firm fixed-price delivery order covers the supply of 100 units of the 60 milligram capsule form of the pharmaceutical drug Vyvanse. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which enables Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,422.11 delivery order is for the supply of Vyvanse 60 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $17,124.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for Vyvanse 60 mg capsules in 100-count bottles. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc., which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,562,306,642 units of Vyvanse 70 mg capsules. The firm-fixed-price delivery order, valued at $1,964.75, has an ultimate completion date of September 27, 2023. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,696.58 for the supply of Vyvanse 40 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 13, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,357.27 delivery order contract is for the supply of Vyvanse 30 mg capsules to support military healthcare programs. The contract has a firm fixed price pricing type and a completion date of February 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,685.23 firm fixed-price delivery order provides the DLA with 4,558,503,628 units of the prescription medication Vyvanse 10 mg capsules. The contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a...
This federal contract award, valued at $1,757.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,560,761 units of Vyvanse 30 mg capsules, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $1,121.24, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order contract is for the supply of Vyvanse 50 mg capsules. It is a firm-fixed-price contract with an ultimate completion date of April 28, 2023. The contract was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger...